Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 33% ± 17% | |
oligodendrocyte | 12 studies | 33% ± 11% | |
endothelial cell | 10 studies | 26% ± 13% | |
oligodendrocyte precursor cell | 8 studies | 27% ± 11% | |
adipocyte | 8 studies | 30% ± 10% | |
microglial cell | 6 studies | 22% ± 5% | |
type I pneumocyte | 6 studies | 25% ± 7% | |
macrophage | 5 studies | 26% ± 5% | |
epithelial cell | 5 studies | 31% ± 16% | |
ciliated cell | 5 studies | 21% ± 6% | |
basal cell | 5 studies | 28% ± 19% | |
club cell | 5 studies | 23% ± 6% | |
fibroblast | 5 studies | 25% ± 7% | |
type II pneumocyte | 5 studies | 19% ± 4% | |
cardiac muscle cell | 4 studies | 19% ± 1% | |
hepatocyte | 3 studies | 36% ± 11% | |
GABAergic neuron | 3 studies | 46% ± 2% | |
glutamatergic neuron | 3 studies | 48% ± 5% | |
ependymal cell | 3 studies | 30% ± 16% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 3% | |
pericyte | 3 studies | 22% ± 6% | |
smooth muscle cell | 3 studies | 20% ± 1% | |
interneuron | 3 studies | 42% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3469.33 | 1445 / 1445 | 100% | 17.52 | 183 / 183 |
intestine | 100% | 3327.96 | 966 / 966 | 100% | 14.94 | 527 / 527 |
pancreas | 100% | 2567.49 | 328 / 328 | 100% | 16.21 | 178 / 178 |
prostate | 100% | 4752.30 | 245 / 245 | 100% | 23.06 | 502 / 502 |
thymus | 100% | 6295.20 | 653 / 653 | 100% | 19.40 | 605 / 605 |
breast | 100% | 3261.27 | 459 / 459 | 100% | 19.82 | 1117 / 1118 |
brain | 100% | 2332.64 | 2637 / 2642 | 100% | 17.24 | 704 / 705 |
liver | 100% | 3008.39 | 226 / 226 | 100% | 13.22 | 404 / 406 |
kidney | 100% | 3757.88 | 89 / 89 | 99% | 20.54 | 896 / 901 |
stomach | 100% | 3220.31 | 359 / 359 | 99% | 14.17 | 284 / 286 |
lung | 100% | 3110.95 | 577 / 578 | 99% | 17.67 | 1148 / 1155 |
adrenal gland | 100% | 4955.52 | 258 / 258 | 99% | 10.42 | 228 / 230 |
bladder | 100% | 4071.24 | 21 / 21 | 99% | 17.03 | 499 / 504 |
uterus | 100% | 3513.47 | 170 / 170 | 99% | 14.93 | 453 / 459 |
ovary | 100% | 4489.46 | 180 / 180 | 99% | 12.17 | 424 / 430 |
skin | 100% | 3936.41 | 1809 / 1809 | 99% | 15.13 | 465 / 472 |
adipose | 100% | 3066.67 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 3691.36 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.50 | 1 / 1 |
blood vessel | 100% | 2692.80 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2115.14 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1754.27 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 15.02 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 95% | 13.38 | 76 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 5.82 | 26 / 29 |
peripheral blood | 30% | 555.26 | 280 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP40 |
Protein name | Ubiquitin specific peptidase 40 Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40) Alternative protein USP40 |
Synonyms | hCG_22796 |
Description | FUNCTION: May be catalytically inactive. |
Accessions | H7C2T9 ENST00000251722.10 [Q9NVE5-1] A0A7I2YQ75 ENST00000443711.2 L8EAZ2 H7C307 H7C0C4 ENST00000454354.1 ENST00000452724.1 ENST00000427112.6 [Q9NVE5-1] ENST00000678225.2 ENST00000450940.5 C9JK14 Q9NVE5 ENST00000430158.5 H7BZ71 |